Matches in SemOpenAlex for { <https://semopenalex.org/work/W2401176062> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2401176062 endingPage "240" @default.
- W2401176062 startingPage "230" @default.
- W2401176062 abstract "Background : The purpose of this study was to develop, implement and evaluate the pharmacist intervention program designed to identify and correctly adjust the dosage of -receptor antagonists () in renally impaired patients and promote timely conversion of from IV to PO therapy. Methods : The study population consisted of renally impaired patients who received therapy from April 9 to May 8, 2001 at Hallym Medical Center. Each morning a specifically developed software program identified patients with serum creatinine (Scr) greater than 1.2 mg/dl or age greater than 65 years. The pharmacist, then screened the pharmacy profiles of the identified patients to determine if the patient was on . For these patients on with renal impairement the creatinine clearance (CrCl) was calculated using Cockroft & Gault equation. The pharmacist determined the proper dosage for each identified patients based on the calculated CrCl and the oral dosage that would be appropriate for whom IV therapy was no longer indicated. Result : A total of 149 cases (101 patients) were monitored during the study period. The dosage was inappropriately prescribed for renal function in 61 of 149 cases (41%), and of those, pharmacist made recommendations for 58 cases of which 33 cases (57%) were accepted by the physicians. The administration route of H2RA was inappropriately used as IV in 22 of 53 cases (42%), and pharmacist made recommendations for those 22 cases of which 15 cases (68%) were accepted. Conclusion : Monitoring of patients with renal dysfunction by a pharmacist improved the dosing of and a dosing program of patients with renal impairment would be of benefit to other clinicians and institutions seeking to optimize patient care." @default.
- W2401176062 created "2016-06-24" @default.
- W2401176062 creator A5044392908 @default.
- W2401176062 creator A5084355067 @default.
- W2401176062 date "2002-01-01" @default.
- W2401176062 modified "2023-09-23" @default.
- W2401176062 title "Evaluation of Pharmacist Intervention Program for Dosage Adjustment and IV-to-PO Conversion for $H_2$-Receptor Antagonist" @default.
- W2401176062 cites W1802548550 @default.
- W2401176062 cites W1947702465 @default.
- W2401176062 cites W2281304498 @default.
- W2401176062 cites W2284458649 @default.
- W2401176062 cites W2338894653 @default.
- W2401176062 cites W2341708185 @default.
- W2401176062 cites W2367408269 @default.
- W2401176062 cites W2391902801 @default.
- W2401176062 cites W2398354031 @default.
- W2401176062 cites W2399632535 @default.
- W2401176062 cites W2401904089 @default.
- W2401176062 cites W2402282186 @default.
- W2401176062 cites W2415930208 @default.
- W2401176062 hasPublicationYear "2002" @default.
- W2401176062 type Work @default.
- W2401176062 sameAs 2401176062 @default.
- W2401176062 citedByCount "0" @default.
- W2401176062 crossrefType "journal-article" @default.
- W2401176062 hasAuthorship W2401176062A5044392908 @default.
- W2401176062 hasAuthorship W2401176062A5084355067 @default.
- W2401176062 hasConcept C10446079 @default.
- W2401176062 hasConcept C104863432 @default.
- W2401176062 hasConcept C126322002 @default.
- W2401176062 hasConcept C126894567 @default.
- W2401176062 hasConcept C159110408 @default.
- W2401176062 hasConcept C159641895 @default.
- W2401176062 hasConcept C194828623 @default.
- W2401176062 hasConcept C2777288759 @default.
- W2401176062 hasConcept C2779457091 @default.
- W2401176062 hasConcept C2780306776 @default.
- W2401176062 hasConcept C2908647359 @default.
- W2401176062 hasConcept C71924100 @default.
- W2401176062 hasConcept C99454951 @default.
- W2401176062 hasConceptScore W2401176062C10446079 @default.
- W2401176062 hasConceptScore W2401176062C104863432 @default.
- W2401176062 hasConceptScore W2401176062C126322002 @default.
- W2401176062 hasConceptScore W2401176062C126894567 @default.
- W2401176062 hasConceptScore W2401176062C159110408 @default.
- W2401176062 hasConceptScore W2401176062C159641895 @default.
- W2401176062 hasConceptScore W2401176062C194828623 @default.
- W2401176062 hasConceptScore W2401176062C2777288759 @default.
- W2401176062 hasConceptScore W2401176062C2779457091 @default.
- W2401176062 hasConceptScore W2401176062C2780306776 @default.
- W2401176062 hasConceptScore W2401176062C2908647359 @default.
- W2401176062 hasConceptScore W2401176062C71924100 @default.
- W2401176062 hasConceptScore W2401176062C99454951 @default.
- W2401176062 hasIssue "2" @default.
- W2401176062 hasLocation W24011760621 @default.
- W2401176062 hasOpenAccess W2401176062 @default.
- W2401176062 hasPrimaryLocation W24011760621 @default.
- W2401176062 hasRelatedWork W1513407415 @default.
- W2401176062 hasRelatedWork W175496275 @default.
- W2401176062 hasRelatedWork W1807094295 @default.
- W2401176062 hasRelatedWork W1988344686 @default.
- W2401176062 hasRelatedWork W1991168476 @default.
- W2401176062 hasRelatedWork W2003824554 @default.
- W2401176062 hasRelatedWork W2067740509 @default.
- W2401176062 hasRelatedWork W2105076447 @default.
- W2401176062 hasRelatedWork W2110577431 @default.
- W2401176062 hasRelatedWork W2132269956 @default.
- W2401176062 hasRelatedWork W2181717431 @default.
- W2401176062 hasRelatedWork W2186800498 @default.
- W2401176062 hasRelatedWork W2211656188 @default.
- W2401176062 hasRelatedWork W2313065170 @default.
- W2401176062 hasRelatedWork W2367408269 @default.
- W2401176062 hasRelatedWork W2604491042 @default.
- W2401176062 hasRelatedWork W2724758879 @default.
- W2401176062 hasRelatedWork W2917770410 @default.
- W2401176062 hasRelatedWork W2940808688 @default.
- W2401176062 hasRelatedWork W2182426784 @default.
- W2401176062 hasVolume "9" @default.
- W2401176062 isParatext "false" @default.
- W2401176062 isRetracted "false" @default.
- W2401176062 magId "2401176062" @default.
- W2401176062 workType "article" @default.